Grant of Options

RNS Number : 2025W
Futura Medical PLC
23 July 2009
 




For immediate release  

23 July 2009




Futura Medical plc

('Futura' or 'the Company')


Grant of Options

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has granted options over a total of 700,000 ordinary shares of 0.2p each in the Company to Directors as detailed below. This grant of options marks the first time since March 2005 that Futura Directors have been awarded options over ordinary shares in the Company.

 

Director

Number of options granted

Exercise price

Exercise period

Total number of options held following notification

Total number of ordinary shares held 

W D Potter

100,000

24.25p

1 Aug 2011 - 31 Jul  2016

100,000

131,098

J H Barder

200,000

24.25p

1 Aug 2011 - 31 Jul 2016

200,000

845,212

D B Davies

200,000

24.25p

1 Aug 2011 - 31 Jul 2016

200,000

532,572

D A Martin

200,000

24.25p

1 Aug 2011 - 31 Jul 2016

400,000

125,000

 

The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise. Derek Martin received 100,000 options on 9 July 2007 and 100,000 options on 20 June 2008 prior to his becoming a Director of the Company. James Barder holds 416,500 shares as a non beneficial interest.


For any further information please contact:


Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670



mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 



Canaccord Adams


Ryan Gaffney / Adria Da Breo-Richards

Tel: +44 (0) 20 7050 6500 



For media enquiries please contact: 




Buchanan Communications


Mark Court / Rebecca Skye Dietrich / Stasa Filiplic

Tel: +44 (0) 20 7466 5000

 

Notes to Editors


Futura Medical plc


Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.


Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFLEDAIVFIA
UK 100

Latest directors dealings